跳至主要内容
临床试验/NCT03150732
NCT03150732已完成不适用

Comparison of Systemic Nalbuphine Versus Intravenous Regional Anesthesia

Assiut University1 个研究点 分布在 1 个国家目标入组 82 人开始时间: 2022年8月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
82
试验地点
1
主要终点
Duration of postoperative Analgesia

研究概览

简要总结

Comparison of systemic nalbuphine versus intravenous regional anesthesia in patients undergoing hand surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients scheduled for elective unilateral hand surgery.

排除标准

  • Patient refusal.
  • Allergy to study medications
  • Body mass index > 35 kg/ m2
  • Patients with sickle cell or Reynaud diseases
  • Patients with a history of psychiatric illness or on chronic opioids

研究组 & 干预措施

Systemic nalbuphine group

Active Comparator

53 patients will receive nalbuphine systemically

干预措施: Systemic nalbuphine (Drug)

Local nalbuphine group

Active Comparator

53 patients will receive nalbuphine with local intravenous regional anesthesia (IVRA)

干预措施: Local nalbuphine (Drug)

结局指标

主要结局

Duration of postoperative Analgesia

时间窗: Postoperative 24 hours

minutes

次要结局

  • Diclofenac analgesic consumption(Postoperative 24 hours)
  • Cortisol level(Preoperative and at 4 hours after skin incision)
  • Severity of postoperative Pain(Postoperative 24 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed Bakri

Professor of anesthesia & ICU

Assiut University

研究点 (1)

Loading locations...

相似试验

Systemic Nalbuphine Versus Intravenous Regional... | 临床试验